dc.contributor.author |
Muñoz Sáez, Emma |
|
dc.contributor.author |
Moracho Pascual, Natalia |
|
dc.contributor.author |
Rodríguez Learte, Ana Isabel
|
|
dc.contributor.author |
Collignon, Alice |
|
dc.contributor.author |
García Arroyo, Alicia |
|
dc.contributor.author |
Noel, Agnés |
|
dc.contributor.author |
Sounni, Nor Eddine |
|
dc.contributor.author |
Sánchez-Camacho Blázquez, Cristina
|
|
dc.date.accessioned |
2023-06-19T17:22:33Z |
|
dc.date.available |
2023-06-19T17:22:33Z |
|
dc.date.issued |
2023 |
|
dc.identifier.citation |
Muñoz-Sáez, E., Moracho, N., Rodríguez Learte, A. I., Collignon, A., Arroyo, A. G., Noel, A., Sounni, N. E., & Sánchez-Camacho, C. (2023). Molecular mechanisms driven by mt4-mmp in cancer progression. International Journal of Molecular Sciences, 24(12), 9944. https://doi.org/10.3390/ijms24129944 |
spa |
dc.identifier.issn |
1422-0067 |
spa |
dc.identifier.issn |
1661-6596 |
spa |
dc.identifier.uri |
http://hdl.handle.net/11268/12153 |
|
dc.description.abstract |
MT4-MMP (or MMP-17) belongs to the membrane-type matrix metalloproteinases (MT-MMPs), a distinct subset of the MMP family that is anchored to the cell surface, in this case by a glycosylphosphatidylinositol (GPI) motif. Its expression in a variety of cancers is well documented. However, the molecular mechanisms by which MT4-MMP contributes to tumor development need further investigation. In this review, we aim to summarize the contribution of MT4-MMP in tumorigenesis, focusing on the molecular mechanisms triggered by the enzyme in tumor cell migration, invasiveness, and proliferation, in the tumor vasculature and microenvironment, as well as during metastasis. In particular, we highlight the putative substrates processed and signaling cascades activated by MT4-MMP that may underlie these malignancy processes and compare this with what is known about its role during embryonic development. Finally, MT4-MMP is a relevant biomarker of malignancy that can be used for monitoring cancer progression in patients as well as a potential target for future therapeutic drug development. |
spa |
dc.description.sponsorship |
Universidad Europea de Madrid (2022/UEM07) |
spa |
dc.description.sponsorship |
National Fund for Scientific Research (FRS-FNRS) (PDR # T.023020) |
spa |
dc.description.sponsorship |
MCIN/AEI/10.13039/501100011033 (PID2020-112981RB-I00) |
spa |
dc.language.iso |
eng |
spa |
dc.rights |
Attribution 4.0 International (CC BY 4.0) |
spa |
dc.rights.uri |
https://creativecommons.org/licenses/by/4.0/ |
spa |
dc.subject.other |
Metaloproteinasa 17 de la matriz |
spa |
dc.title |
Molecular Mechanisms Driven by MT4-MMP in Cancer Progression |
spa |
dc.type |
article |
spa |
dc.description.impact |
5.6 Q1 JCR 2022 |
spa |
dc.description.impact |
1.154 Q1 SJR 2022 |
spa |
dc.description.impact |
No data IDR 2022 |
spa |
dc.identifier.doi |
10.3390/ijms24129944 |
|
dc.rights.accessRights |
openAccess |
spa |
dc.subject.unesco |
Cáncer |
spa |
dc.subject.unesco |
Biología molecular |
spa |
dc.description.filiation |
UEM |
spa |
dc.relation.publisherversion |
https://doi.org/10.3390/ijms24129944 |
spa |
dc.peerreviewed |
Si |
spa |